The Valley Desk

NCT03777657 · Interventional trial

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

Overall registry status Completed

Phase 3

Conditions Gastric, or Gastroesophageal Junction Adenocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov